Asenapine maleate

Catalog No. A10091

Asenapine maleate平对多种受体具有高亲和力(pKi),包括5-羟色胺5-HT1A(8.6),5-HT1B(8.4),5-HT2A(10.2),5-HT2B(9.8),5-HT2C(10.5),5 -HT5A(8.8),5-HT6(9.5)和5-HT7(9.9)受体,肾上腺素α1(8.9),α2A(8.9),α2B(9.5)和α2C(8.9)受体,多巴胺D1( 8.9),D2(8.9),D3(9.4)和D4(9.0)受体以及组胺H1(9.0)和H2(8.2)受体。
  • Keisuke Obara, .et al. Inhibitory Effects of Antipsychotics on the Contractile Response to Acetylcholine in Rat Urinary Bladder Smooth Muscles, Biol Pharm Bull, 2021, 44, 1140-1150
Catalog Num A10091
M. Wt 401.84
Formula C17H16ClNO.C4H4O4
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 85650-56-2
Synonyms
SMILES CN1C[C@H]2[C@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24.C(=C\C(=O)O)\C(=O)O
Asenapine maleate平对多种受体具有高亲和力(pKi),包括5-羟色胺5-HT1A(8.6),5-HT1B(8.4),5-HT2A(10.2),5-HT2B(9.8),5-HT2C(10.5),5 -HT5A(8.8),5-HT6(9.5)和5-HT7(9.9)受体,肾上腺素α1(8.9),α2A(8.9),α2B(9.5)和α2C(8.9)受体,多巴胺D1( 8.9),D2(8.9),D3(9.4)和D4(9.0)受体以及组胺H1(9.0)和H2(8.2)受体。
Targets
Target Value
5-HT2Cpki: 10.46
5-HT2Apki: 10.15
5-HT7pki: 9.94
5-HT2Bpki: 9.75
5-HT6pki: 9.6
α2B-adrenergicreceptorpki: 9.49
D3receptorpki: 9.38
H1receptorpki: 9
D4receptorpki: 8.95
α1A-adrenergicreceptorpki: 8.93
α2C-adrenergicreceptorpki: 8.91
D2LReceptorpki: 8.9
α2A-adrenergicreceptorpki: 8.9
D1receptorpki: 8.85
5-HT5Apki: 8.84
D2SReceptorpki: 8.84
5-HT1Apki: 8.6
5-HT1Bpki: 8.4
H2receptorpki: 8.21
In vitro DMSO 78 mg/mL (194.1 mM)
Water Insoluble
Ethanol Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 24.89 mL 124.43 mL 248.86 mL
0.5 mM 4.98 mL 24.89 mL 49.77 mL
1 mM 2.49 mL 12.44 mL 24.89 mL
5 mM 0.5 mL 2.49 mL 4.98 mL

*The above data is based on the productmolecular weight 401.84. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.